Related Experiment Videos
Dopamine D2 receptor dimers and receptor-blocking peptides
1Department of Pharmacology, University of Toronto, Ontario, Canada.
Biochemical and Biophysical Research Communications
|October 3, 1996
Summary
Dopamine D2 receptors form dimers, which can be dissociated by specific peptides. This finding may lead to new therapies targeting receptor interactions.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Dopamine D2 receptors are crucial in neurological functions.
- Receptor dimerization is increasingly recognized as important for protein function.
Purpose of the Study:
- To investigate the oligomeric state of dopamine D2 receptors.
- To explore the role of transmembrane domains in receptor dimerization.
- To identify potential therapeutic targets based on receptor interactions.
Main Methods:
- Analysis of dopamine D2 receptors in human caudate tissue.
- Photoaffinity labeling to distinguish monomers and dimers.
- Treatment with transmembrane domain peptides, high temperature, and low pH to induce dissociation.
Main Results:
- Dopamine D2 receptors exist as dimers in cellular preparations and after solubilization.
- Spiperone selectively labels monomers, while nemonapride targets dimers.
- Specific peptides from D2 receptor transmembrane domains, high temperature, and low pH dissociate D2 dimers into monomers.
- D2-TM peptides did not affect dopamine D1 or serotonin 5-HT1B receptor dimers.
Conclusions:
- Dopamine D2 receptor dimerization involves specific intermolecular noncovalent interactions within transmembrane regions.
- This dimerization mechanism offers a novel strategy for developing selective therapeutic agents.